Enhancing the antimycobacterial efficacy of pyridine-4-carbohydrazide: linkage to additional antimicrobial agents via oxocarboxylic acids
2025

Improving Antimycobacterial Activity of Pyridine-4-Carbohydrazide

publication 10 minutes Evidence: high

Author Information

Author(s): Pflégr Václav, Konečná Klára, Stolaříková Jiřina, Ősterreicher Jan, Janďourek Ondřej, Krátký Martin

Primary Institution: Charles University

Hypothesis

Linking pyridine-4-carbohydrazide to other antimicrobial agents via oxocarboxylic acids will enhance its efficacy against mycobacteria.

Conclusion

The study found that many derivatives of pyridine-4-carbohydrazide exhibited potent antimycobacterial activity, outperforming the standard drug isoniazid.

Supporting Evidence

  • Many derivatives exhibited potent antimycobacterial activity with MICs as low as ≤0.25 μM.
  • Compounds were effective against multidrug-resistant strains at higher concentrations.
  • The cytotoxicity assay indicated a favorable safety profile with no significant hemolysis at 125 μM.

Takeaway

Scientists combined a tuberculosis drug with other medicines to make it work better against germs that cause tuberculosis.

Methodology

The study synthesized various derivatives of pyridine-4-carbohydrazide and tested their antimycobacterial activity against different strains.

Limitations

The study primarily focused on in vitro results, and further in vivo studies are needed to confirm efficacy.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1039/d4md00663a

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication